BioXcel Therapeutics (BTAI) PT Raised to $21 at BMO Capital

May 23, 2019 7:53 AM EDT Send to a Friend

BMO Capital analyst Do Kim raised the price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioXcel Therapeutics (BTAI) PT Raised to $21 at BMO Capital

Member Login

Free News Feed